188 related articles for article (PubMed ID: 38480853)
61. Upregulation of Synuclein-
Yang J; Pan Y; Peng L; Zhang L; Zhao J; Zheng Z; Zheng J; Xu X; Zeng Y
Biomed Res Int; 2022; 2022():6534626. PubMed ID: 35434126
[TBL] [Abstract][Full Text] [Related]
62. High Expression of E2F4 Is an Adverse Prognostic Factor and Related to Immune Infiltration in Oral Squamous Cell Carcinoma.
Zheng Y; Fei H
Biomed Res Int; 2022; 2022():4731364. PubMed ID: 36567912
[TBL] [Abstract][Full Text] [Related]
63. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
64. Inflammatory response-related genes predict prognosis in patients with HNSCC.
Jing SL; Afshari K; Guo ZC
Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
[TBL] [Abstract][Full Text] [Related]
65. Identification of an Immune Score-Based Gene Panel with Prognostic Power for Oral Squamous Cell Carcinoma.
Huang SN; Li GS; Zhou XG; Chen XY; Yao YX; Zhang XG; Liang Y; Li MX; Chen G; Huang ZG; Dang YW; Li J; Li P; Tang XZ; Rong MH
Med Sci Monit; 2020 Jun; 26():e922854. PubMed ID: 32529991
[TBL] [Abstract][Full Text] [Related]
66. Identification of Prognostic and Tumor Microenvironment by Shelterin Complex-Related Signatures in Oral Squamous Cell Carcinoma.
Zhang S; Yu H; Li J; Zhao L; Tan L; Song Q; Sun C
Oxid Med Cell Longev; 2022; 2022():6849304. PubMed ID: 35757510
[TBL] [Abstract][Full Text] [Related]
67. Identification of biomarkers related to glycolysis with weighted gene co-expression network analysis in oral squamous cell carcinoma.
Zhou X; Xue D; Qiu J
Head Neck; 2022 Jan; 44(1):89-103. PubMed ID: 34713497
[TBL] [Abstract][Full Text] [Related]
68. Gene signature predicting recurrence in oral squamous cell carcinoma is characterized by increased oxidative phosphorylation.
Noh JK; Woo SR; Kong M; Lee MK; Lee JW; Lee YC; Ko SG; Eun YG
Mol Oncol; 2023 Jan; 17(1):134-149. PubMed ID: 36271693
[TBL] [Abstract][Full Text] [Related]
69. Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway.
Huang G; Chen S; Washio J; Paka Lubamba G; Takahashi N; Li C
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768316
[TBL] [Abstract][Full Text] [Related]
70. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R
Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387
[TBL] [Abstract][Full Text] [Related]
71. A two-CpG-based prognostic signature for oral squamous cell carcinoma overall survival.
Chen Y; Hei N; Zhao J; Peng S; Yang K; Chen H; Cui Z; Jin L; Sun R; Guo J
J Cell Biochem; 2019 Jun; 120(6):9082-9090. PubMed ID: 30548666
[TBL] [Abstract][Full Text] [Related]
72. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
Lin X; Ding JM; Zheng XZ; Chen JG
Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
[TBL] [Abstract][Full Text] [Related]
73. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
74. Integrated Single-cell and Bulk RNA Sequencing Analysis Cross Talk between Ferroptosis-related Genes and Prognosis in Oral Cavity Squamous Cell Carcinoma.
Lan T; Ren S; Hu H; Wang R; Chen Q; Wu F; Xu Q; Li Y; Shao L; Wang L; Liu X; Cao H; Li J
Recent Pat Anticancer Drug Discov; 2024; 19(3):354-372. PubMed ID: 38214321
[TBL] [Abstract][Full Text] [Related]
75. A Signature of N
Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
Front Immunol; 2022; 13():809872. PubMed ID: 35185897
[TBL] [Abstract][Full Text] [Related]
76. Corneodesmosin as a potential target of oral squamous cell carcinoma.
Di YB; Bao Y; Guo J; Liu W; Zhang SX; Zhang GH; Li TK
Medicine (Baltimore); 2022 Sep; 101(39):e28397. PubMed ID: 36181011
[TBL] [Abstract][Full Text] [Related]
77. Identification of Candidate Target Genes and Immune Cells in Oral Squamous Cell Carcinoma.
Xie P; Wu S; Guo L; Ren J; Cai K; Zhou M; Liu W; Yang S
Comput Math Methods Med; 2021; 2021():5802110. PubMed ID: 35003322
[TBL] [Abstract][Full Text] [Related]
78. Poor Prognosis of Oral Squamous Cell Carcinoma Correlates With ITGA6.
Zhang C; Cai Q; Ke J
Int Dent J; 2023 Apr; 73(2):178-185. PubMed ID: 35820930
[TBL] [Abstract][Full Text] [Related]
79. Identification and validation of genes associated with copper death in oral squamous cell carcinoma based on machine learning and weighted gene co-expression network analysis.
Zhang M; Li Q; Zhang W; Yang Y; Gu J; Dong Q
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101561. PubMed ID: 37451513
[TBL] [Abstract][Full Text] [Related]
80. Porphyromonas gingivalis Activation of Tumor-Associated Macrophages via DOK3 Promotes Recurrence of Oral Squamous Cell Carcinoma.
Li CX; Su Y; Gong ZC; Liu H
Med Sci Monit; 2022 Oct; 28():e937126. PubMed ID: 36210538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
